Medmix AG is a global leader in high-precision delivery devices and fluid mixing systems for healthcare, consumer, and industrial applications. Formed as a spin-off from Sulzer Group's Applicator Syst... Medmix AG is a global leader in high-precision delivery devices and fluid mixing systems for healthcare, consumer, and industrial applications. Formed as a spin-off from Sulzer Group's Applicator Systems division in 2021, it specializes in innovative technologies inspired by over a century of expertise, holding more than 900 active patents. The company excels in healthcare segments including dental solutions under MIXPAC™ and transcodent™ brands—such as one- and two-component mixing systems, syringes, needles for injection, irrigation, and suction—as well as drug delivery devices like proprietary pen injectors under Haselmeier™, and surgery tools like bone cement mixers. In consumer markets, it leads with microbrushes for beauty applications via Geka, while industrial offerings include dispensers for adhesives from brands like PC Cox and Kroeger. With 14 manufacturing sites and sales offices across Europe, the Americas, and Asia, and nearly 2,700 employees, Medmix AG ensures quality, proximity, and flexibility, serving pharma, dental professionals, beauty brands, and industrial clients worldwide through strategic growth including acquisitions like Qiaoyi and alliances with AARDEX.
Financial Fundamentals data not yet covered for medmix
We have not yet reviewed medmix's disclosures for Financial Fundamentals data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.